A Study of Some Hormonal and Chemical Indicators in Iraqian Women with Polycystic Ovary Syndrome in Al-Najaf Governorates
Mohsin K. Almurshdi, Teebah Talib Abdulridha, Fatimah Najm Abdzaid
Abstract
The aim of this study was to determine and evaluated the Some clinical features, reproductive hormones and Lipid profile in women with PCOS-Blood samples were collected from Al-Sadr Medical Teaching Hospital in AL-NAJAF City Iraq during the Period between October 2022 to January 2023. This Samples included 50 females with polycystic ovary Syndrome (PCOS) compared with 25 healthy females as a control group. Current study revealed several changes found in clinical symptoms of PCOS patients of PCOS Patients Like rate increment of Hirsutism (78%), Family History (42%), recurrent abortion (34%), irregular menstrual period (62%) and infertility (68%) comparing to women with PCOS who they show those symptoms. No difference found for age between Patients and control groups, while significant increase (P<0.05) for Body mass Index in women with PCOS compared to control group.
This study revealed a significant increase (P<0.05) for FSH, LH, Prolactin and testosterone for women with PCOS compared to control group. While estrogen and progesterone were significant decrease (P<0.05).
Lipid profile in women with PCOS and control group demonstrated statistically highly significant difference (P<0.01) between both groups regarding Serum total cholesterol, Serum triglycerides, VLDL and LDL. while, significant decrease (P<0.05) for HDL for women PCOS compared to control group.
Full Text: PDF DOI: 10.15640/ijhs.v11n1a13
Today
All Days
Online